Suchergebnisse - "Siegel, David S."

PubPharm (136)

1

Idecabtagene vicleucel for relapsed and refractory multiple myeloma : post hoc 18-month follow-up of a phase 1 trial

enthalten in: Nature medicine | 2023

von Lin, Y. | Raje, N. | Berdeja, J. | +19

2

Inhibition of NF-κB DNA Binding Suppresses Myeloma Growth via Intracellular Redox and Tumor Microenvironment Modulation

enthalten in: Molecular cancer therapeutics | 2022

von Bariana, M. | Cassella, E. | Rateshwar, J. | +11

3

I-OPen : inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients

enthalten in: Blood cancer journal | 2022

von Gill, S. | Unawane, R. | Wang, S. | +7

4

Pomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma : updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial

enthalten in: Leukemia & lymphoma | 2022

von Bahlis, N. | Siegel, D. | Schiller, G. | +17

5

Sustained Hematopoietic Engraftment Potential after Prolonged Storage of Cryopreserved Hematopoietic Stem Cells Used in Salvage Autologous Stem Cell Transplantation

enthalten in: Transplantation and cellular therapy | 2022

von Makhani, S. | Oza, S. | Reich-Slotky, R. | +7

6

Natural killer cells activity against multiple myeloma cells is modulated by osteoblast-induced IL-6 and IL-10 production

enthalten in: Heliyon | 2022

von Uhl, C. | Nyirenda, T. | Siegel, D. | +2

7

Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States

enthalten in: Patient preference and adherence | 2022

von Auclair, D. | Mansfield, C. | Fiala, M. | +10

8

Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma : a multicentre, phase 1/2a study

enthalten in: The Lancet. Haematology | 2021

von Kelly, K. | Ailawadhi, S. | Siegel, D. | +18

CommentIn: Lancet Haematol. 2021 Nov;8(11):e778-e779. - PMID 34529956

9

Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma

enthalten in: American journal of hematology | 2021

von Biran, N. | Gourna Paleoudis, E. | Feinman, R. | +14

10

Immune tolerance with combined allogeneic haplo-identical haematopoietic stem cell transplant and renal transplant

enthalten in: British journal of haematology | 2021

von Doucette, K. | Shah, N. | Donato, M. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]